Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH)

Market Closed
21 Jul, 20:00
NYSE NYSE
$
88. 92
-0.8
-0.8917%
$
17.63B Market Cap
24.97 P/E Ratio
0.96% Div Yield
1.15M Volume
8.06 Eps
$ 89.72
Previous Close
Add Transaction
Day Range
88.25 90
Year Range
79.12 108.29
Want to track ZBH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Zimmer Biomet beats profit estimates on strong demand for medical devices

Zimmer Biomet beats profit estimates on strong demand for medical devices

Zimmer Biomet Holdings beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for its devices used in joint reconstruction procedures.

Reuters | 1 year ago
Exploring Analyst Estimates for Zimmer (ZBH) Q2 Earnings, Beyond Revenue and EPS

Exploring Analyst Estimates for Zimmer (ZBH) Q2 Earnings, Beyond Revenue and EPS

Beyond analysts' top -and-bottom-line estimates for Zimmer (ZBH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.

Zacks | 1 year ago
Here's How Zimmer Biomet (ZBH) is Poised Ahead of Q2 Earnings

Here's How Zimmer Biomet (ZBH) is Poised Ahead of Q2 Earnings

Zimmer Biomet (ZBH) is expected to have witnessed procedure volume recovery banking on strategic product launches in the second quarter.

Zacks | 1 year ago
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term

Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock

Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
Zimmer Biomet: Brighter Prospects In H2 2024

Zimmer Biomet: Brighter Prospects In H2 2024

Zimmer Biomet's share price has been under pressure in recent months due to soft growth, poor cash flows, and higher interest rates. Demographics, the rise of ASCs and technological advancements should be supportive of long-term growth. Zimmer Biomet also expects new product launches to accelerate growth in the second half of 2024.

Seekingalpha | 2 years ago
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.

Benzinga | 2 years ago
Zimmer Biomet (ZBH) Advances in GenAI Technology With RevelAi

Zimmer Biomet (ZBH) Advances in GenAI Technology With RevelAi

Zimmer Biomet (ZBH) and RevelAi Health have joined forces to solve social and clinician problems by commercializing RevelAi's patient care-management platform and care team dashboard for providers.

Zacks | 2 years ago
Zimmer Biomet (ZBH) to Broaden Knee Surgery Line With New Alliance

Zimmer Biomet (ZBH) to Broaden Knee Surgery Line With New Alliance

Zimmer Biomet (ZBH) joins forces with Think Surgical for the distribution of customized TMINI - Miniature Robotic System in the U.S. market.

Zacks | 2 years ago
Zimmer Biomet (ZBH) Procedure Recovery Aids Amid Macro Woes

Zimmer Biomet (ZBH) Procedure Recovery Aids Amid Macro Woes

Zimmer Biomet (ZBH) continues to record strong procedure volume in 2024 in both the Knees and Hips businesses, banking on an improved market scenario.

Zacks | 2 years ago
Zimmer Biomet (ZBH) Unlocks Growth Plan for Future Success

Zimmer Biomet (ZBH) Unlocks Growth Plan for Future Success

Zimmer Biomet (ZBH) outlines a path for compelling and long-term topline growth, improved operational profitability, and increased free cash flow generation.

Zacks | 2 years ago
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?

Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago